Cargando…
SDH-deficient renal cell carcinoma – clinical, pathologic and genetic correlates: a case report
BACKGROUND: Succinate dehydrogenase (SDH)- deficient renal cell carcinoma (RCC) is a newly identified rare subtype of RCC, having only gained acceptance from the World Health Organization in 2016. To the best of our knowledge, there are only 55 reported cases worldwide. Here, we report a new case of...
Autores principales: | Kumar, Ravi, Bonert, Michael, Naqvi, Asghar, Zbuk, Kevin, Kapoor, Anil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258450/ https://www.ncbi.nlm.nih.gov/pubmed/30482207 http://dx.doi.org/10.1186/s12894-018-0422-8 |
Ejemplares similares
-
Genomic and Metabolic Hallmarks of SDH- and FH-deficient Renal Cell Carcinomas
por: Yoo, Angela, et al.
Publicado: (2022) -
Defining the origin, evolution, and immune composition of SDH-deficient renal cell carcinoma
por: Neves, Joana B., et al.
Publicado: (2022) -
SDH‐deficient renal cell carcinoma: A case report associated with a novel germline mutation
por: Milionis, Vassilis, et al.
Publicado: (2021) -
Targeted therapy in SDH-deficient GIST
por: Nannini, Margherita, et al.
Publicado: (2021) -
Genomic and Clinical Correlates of Adrenocortical Carcinoma in an Adult Patient with Li-Fraumeni Syndrome: A Case Report
por: Bondy, Suraya, et al.
Publicado: (2020)